0001213900-22-020351.txt : 20220418 0001213900-22-020351.hdr.sgml : 20220418 20220418144217 ACCESSION NUMBER: 0001213900-22-020351 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220418 DATE AS OF CHANGE: 20220418 EFFECTIVENESS DATE: 20220418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Saliogen Therapeutics, Inc. CENTRAL INDEX KEY: 0001845309 IRS NUMBER: 844170116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-423901 FILM NUMBER: 22831909 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 990-2200 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0001845309 Saliogen Therapeutics, Inc. 245 FIRST STREET 18TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 (857) 990-2200 DELAWARE None None Corporation true 2020 Raymond Tabibiazar 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Joseph Higgins 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Sukumar Nagendran 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Director While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. Sean Stalfort 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Director Craig Gordon 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b true 0001213900-21-063813 2021-11-24 false true false 0 132249385 132249385 0 false 24 0 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Saliogen Therapeutics, Inc. /s/ Raymond Tabibiazar Raymond Tabibiazar Chief Executive Officer 2022-04-18